|
391 |
S2k-Leitlinie „Harninkontinenz bei geriatrischen Patienten“ – Teil 3: Operative Therapie der Harninkontinenz Enthalten in Aktuelle Urologie Bd. 55, 2024, Nr. 06: 549-554
|
|
|
392 |
Proton Pump Inhibitors and Kidney Disease: Fact or Fiction? Enthalten in American journal of nephrology Bd. 55, 2024, Nr. 4: 499-508. 9 S.
|
|
|
393 |
Difelikefalin in Black/African American Hemodialysis Patients with Moderate-to-Severe Pruritus: Post hoc Analysis of KALM-1 and KALM-2 Enthalten in American journal of nephrology Bd. 55, 2024, Nr. 3: 329-333. 5 S.
|
|
|
394 |
Methods Article for a Study Protocol: Study Design and Baseline Characteristics for Aldosterone Synthase Inhibition in Chronic Kidney Disease Enthalten in American journal of nephrology Bd. 55, 2024, Nr. 2: 262-272. 10 S.
|
|
|
395 |
Use of oral devices in the management of oral dysesthesia: case reports and literature review Enthalten in Quintessence international Bd. 55, 2024, Nr. 1: 60-67
|
|
|
396 |
Efficacy and Safety of Chinese Herbal Medicine in Patients with Acute Intracerebral Hemorrhage: Protocol for a Randomized Placebo-Controlled Double-Blinded Multicenter Trial Enthalten in Cerebrovascular diseases Bd. 53, 2024, Nr. 4: 501-508. 7 S.
|
|
|
397 |
Effects of sildenafil on Doppler parameters, maternal and neonatal outcomes in the active labor phase of low-risk pregnancies: a randomized clinical trial Enthalten in Journal of perinatal medicine Bd. 52, 2024, Nr. 2: 210-214. 05 S.
|
|
|
398 |
Mechanismen der Placebo- und Noceboantwort verstehen und in der klinischen Praxis nutzen Enthalten in Gynäkologische Praxis Bd. 051, 2024, Nr. 04
|
|
|
399 |
Akne-induzierte Hyperpigmentierung: Trifaroten versus Placebo Enthalten in Aktuelle Dermatologie Bd. 50, 2024, Nr. 12: 543-543
|
|
|
400 |
Kommentar zu: Positive Effekte von Probiotika bei Leberzirrhose nachgewiesen Enthalten in Aktuelle Ernährungsmedizin Bd. 49, 2024, Nr. 03: 198-199
|
|